SLC6A1 and Neurodevelopmental delay: Indeed, the most consistent clinical features of the SLC6A1-NDD carriers are ID varying from mild to severe, behavioral and attention deficit hyperactivity disorders, and developmental delay that have been reported in almost all patients.